How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?

Aleksander Salomon-Perzyński, Bożena Katarzyna Budziszewska

Vol 14 (2023): Continuous Publishing

Review paper

IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia

Bartosz Puła, Krzysztof Jamroziak, Tomasz Wróbel, Krzysztof Giannopoulos, Iwona Hus

Vol 13, No 1 (2022)

Review paper

Oral manifestations of leukaemia: cooperation between dentist and haematologist

Ewa Michalak, Agata Dudzik, Joanna Śręba, Barbara Kęsek, Dagmara Darczuk

Vol 13, No 2 (2022)

Case report

Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine

Katarzyna Korzeniowska, Artur Cieślewicz, Anna Flotyńska, Anna Jabłecka

Vol 13, No 1 (2022)

Case report

Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy

Andrzej Szczepaniak, Lidia Gil, Sebastian Giebel, Grzegorz Helbig, Tomasz Wróbel, Jan Maciej Zaucha, Bożena Budziszewska, Agnieszka Wierzbowska

Vol 13, No 3-4 (2022)

Review paper

Adverse events of monoclonal antibodies use in therapy of hematological malignancies

Marcela Maksymowicz, Monika Podhorecka

Vol 12, No 3-4 (2021)

Review paper

JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms

Michał Łączak, Martyna Kuczyńska, Joanna Grygier, Dominika Andrzejewska, Wiktoria Grochowska, Hanna Gulaczyk, Krzysztof Lewandowski

Vol 12, No 3-4 (2021)

Review paper

Eosinophilia caused by Toxocara canis infection

Monika Kowalik, Aleksandra Gołos, Joanna Góra-Tybor

Vol 13, No 2 (2022)

Case report

Therapeutic options in high-risk myelodysplastic syndrome

Marcela Maksymowicz, Sara Moqbil, Piotr Machowiec, Monika Podhorecka

Vol 13, No 3-4 (2022)

Review paper

Treatment of a patient with acute myeloid leukaemia with FLT3-ITD mutation

Katarzyna Jerzmanowska, Agnieszka Pluta

Vol 13, No 1 (2022)

Case report

Pulmonary embolism after anti-SARS-CoV-2 vaccines in two female patients

Katarzyna Korzeniowska, Artur Cieślewicz, Katarzyna Grabańska-Martyńska, Anna Flotyńska, Anna Jabłecka

Vol 14 (2023): Continuous Publishing

Case report

Effective treatment of severe forms of RSV and Pneumocystis jirovecii infections in a child with Down syndrome and acute lymphoblastic leukemia treated with chemotherapy

Magdalena Ostojska, Katarzyna Karska, Monika Lejman, Joanna Zawitkowska

Vol 14 (2023): Continuous Publishing

Case report

Diagnosis and treatment of immune thrombocytopenia in Poland

Piotr Małecki, Sebastian Grosicki

Vol 13, No 2 (2022)

Review paper

Oral iron absorption test: myth or reality?

Samet Yaman, Yağmur Kınacı Gümüşçubuk, Oğuzcan Gümüşçubuk, Berkan Karabuğa, Sema Akinci, İmdat Dilek

Vol 14 (2023): Continuous Publishing

Research paper

Hematological manifestations of X-linked lymphoproliferative disease

Natalia Aleksandra Dułak, Jadwiga Juwa, Rafał Trzciński, Alan Majeranowski, Ninela Irga-Jaworska

Vol 13, No 1 (2022)

Review paper

Antithrombotic prophylaxis in patients treated with Bruton’s tyrosine kinase inhibitors

Sebastian Szmit

Vol 14 (2023): Continuous Publishing

Review paper

Waldenström macroglobulinemia: diagnosis and treatment

Krzysztof Giannopoulos

Vol 13, No 3-4 (2022)

Review paper

Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features

Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska

Vol 13, No 1 (2022)

Case report

Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH

Joseph Alburqueque-Melgarejo, Juan Carlos Roque-Quezada, Javier Dulanto Moscoso, Emanuel Salcedo Davila, Brady Beltrán Gárate

Vol 13, No 3-4 (2022)

Case report

Haemophagocytic lymphohistiocytosis: case series. Serum ferritin level as an indicator of treatment effectiveness

Daria Majowicz, Konrad Kostrzewa, Tomasz Gromek, Bożena Sokołowska, Marek Hus

Vol 13, No 3-4 (2022)

Case report

Midostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation

Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska

Vol 13, No 1 (2022)

Case report

Clinical and demographic characteristics of sickle cell disease in colombian children

Sara Maria Soto, Carlos Andres Portilla, Herney Andrés García-Perdomo

Vol 14 (2023): Continuous Publishing

Research paper

Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland

Krzysztof Giannopoulos, Krzysztof Jamroziak, Tomasz Wróbel, Dominik Dytfeld

Vol 13, No 2 (2022)

Review paper

Study of type and frequency of Alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran

Parvaneh Tavakoli Afshar, Zohreh Taherian, Negar Nouri, Erfan Zaker, Sara Asadi, Farzaneh Rami, Roya Bakhtiari, Majid Hosseinzadeh, Mansoor Salehi

Vol 14 (2023): Continuous Publishing

Research paper

Midostaurin added to standard therapy in FLT3-positive acute myeloid leukaemia treatment

Andrzej Szczepaniak, Zuzanna Rzetelska

Vol 13, No 2 (2022)

Case report